本页面由Tiger Trade Technology Pte. Ltd.提供服务

ARS PHARMACEUTICALS INC

7.94
-0.2900-3.52%
盘后7.91-0.0300-0.38%19:19 EDT
成交量:248.60万
成交额:2,000.26万
市值:7.85亿
市盈率:-3.96
高:8.29
开:8.23
低:7.91
收:8.23
52周最高:18.90
52周最低:6.66
股本:9,884.86万
流通股本:5,527.05万
量比:1.11
换手率:4.50%
股息:- -
股息率:- -
每股收益(TTM):-2.0044
每股收益(LYR):-1.7400
净资产收益率:-136.40%
总资产收益率:-41.15%
市净率:12.80
市盈率(LYR):-4.56

数据加载中...

2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/06

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/18

SEC问询函

Form CORRESP - Correspondence
2024/11/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities